Home › Long COVID › California › Sacramento
Long COVID clinical trials in Sacramento, CA
3 studies for Long COVID are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- UC Davis CTSC Clinical Research Center, Sacramento
- University of California Davis Health, Sacramento
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- University of California Davis Health System, Sacramento
Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
RecruitingEarly phase 1Healthy volunteers welcome
- UC Davis EXPLORER Molecular Imaging Center, Sacramento
About Long COVID
Anyone who has had COVID-19 can have long-lasting symptoms, know as long COVID. Learn about the symptoms and how to manage them, diagnosis, and prevention.
More about Long COVID on MedlinePlus
Long COVID trials in other cities
- New York City, NY17 studies
- Houston, TX14 studies
- Chicago, IL12 studies
- Washington, DC12 studies
- Boston, MA11 studies
- Baltimore, MD11 studies
- Hialeah, FL8 studies
- Durham, NC8 studies
- San Francisco, CA8 studies
- Atlanta, GA7 studies
- San Diego, CA7 studies
- Miami, FL7 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer23 studies
- Prostate Cancer20 studies
- Breast Cancer19 studies
- Metastatic Cancer17 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Colon Cancer12 studies
- Cancer (all types)11 studies
- Colorectal Cancer11 studies
- Pancreatic Cancer11 studies
- Bladder Cancer10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.